FINECROSS M3-1430Recalls & reported problems
Terumo Corporation · FineCross M3 Coronary Micro-Guide Catheter · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04987892058875), received between Feb 18, 2026 and Feb 18, 2026 — classified as 2 injuries.
The most frequently reported specific device problem is “Material Separation” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Material Separation2
Patient problems
- Foreign Body In Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryFeb 18, 2026Material Separation
TERUMO MEDICAL CORPORATION RECEIVED THE FOLLOWING REPORTED INFORMATION: THE RESIDUAL TIP WAS ATTEMPTED TO BE SNARED OUT; HOWEVER, IT WAS UNSUCCESSFUL. IT WAS LEFT IN BODY, ASSUMED IT WAS BEHIND SOME PAPILLARY MUSCLE. THE PATIENT WAS STABLE. THERE WERE NO ADDITIONAL MEASURES TO REMOVE THE RESIDUAL TIP, IT WAS FOREVER A PART OF THE PATIENT.
Patient problems: Foreign Body In Patient
MAUDE report 24379864 ↗InjuryFeb 18, 2026Material Separation
TERUMO RECEIVED THE FOLLOWING REPORTED INFORMATION: THE DEVICE WAS INSERTED OVER A PILOT 200 THROUGH A CHRONIC TOTAL OCCLUSION (CTO) OF THE LEFT ARTERY DESCENDING (LAD) THAT WAS HEAVILY CALCIFIED. THE LESION WAS TREATED WITH A 1.5 TAKERU BEFORE INSERTION OF THE M3. THE M3 DID NOT MAKE IT ALL THE WAY DOWN THE VESSEL. AFTER MANIPULATION OF THE M3, IT APPEARED THAT A PORTION OF THE TIP OF THE M3 BROKE OFF AND WAS IN THE VESSEL. MULTIPLE MICRO CATHETERS, WIRES, AND BALLOONS WERE USED TO OPEN THE LESION. THE PATIENT WILL BE BROUGHT BACK IN 2-4 WEEKS TO COVER THE TIP WITH A STENT. IT WAS BELIEVED THE TIP IS IN THE SUB INTIMAL SPACE OF THE LAD. THE BLOOD LOSS WAS LESS THAN 250CC. THE PATIENT WAS STABLE. THE DEVICE WAS NOT CONTAMINATED BY INFECTIOUS AGENTS OR ANTI-CANCER AGENTS.
Patient problems: Foreign Body In Patient
MAUDE report 24379862 ↗
Other Catheter, percutaneous devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page